3.8 Article

Effects of probiotic Lactobacillus salivarius WB21 on halitosis and oral health: an open-label pilot trial

Publisher

MOSBY-ELSEVIER
DOI: 10.1016/j.tripleo.2010.03.032

Keywords

-

Funding

  1. Ministry of Education, Culture, Sports, Technology and Science, Japan [20592249, 20592444, 21890187]
  2. Mitsui Sumitomo Insurance Welfare Foundation
  3. Sagami Research Laboratories, Wakamoto Pharmaceutical Co., Ltd.
  4. Grants-in-Aid for Scientific Research [21890187, 20592444, 20592249] Funding Source: KAKEN

Ask authors/readers for more resources

Objective. The objective of this study was to evaluate whether oral administration of lactobacilli alters the degree of halitosis and clinical conditions associated with halitosis. Study design. Twenty patients with genuine halitosis were given 2.0 x 10(9) Lactobacillus salivarius WB21 and xylitol in tablet form daily. Oral malodor and clinical parameters were evaluated at the same time of day for each patient after 2 and 4 weeks. Results. All 20 patients were positive for L. salivarius DNA in their saliva at 2 weeks, although 12 patients were negative for this organism at baseline. Oral malodor parameters significantly decreased at 2 weeks in the subjects with physiologic halitosis. The scores of an organoleptic test and bleeding on probing significantly decreased at 4 weeks in the subjects with oral pathologic halitosis. Conclusions. Oral administration of probiotic lactobacilli primarily improved physiologic halitosis and also showed beneficial effects on bleeding on probing from the periodontal pocket. (Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2010; 110: 201-208)

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

3.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available